DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

Clinical trial NCT07142278 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07142278
Sponsor: Nuravax, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Alzheimer Disease (AD)Preclinical Alzheimer's Disease

Start date: 2025-11-01
Primary completion: 2027-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.